EL0934 |
MRAK052686 |
Nonalcoholic fatty liver disease |
N/A |
N/A |
N/A |
N/A |
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles. MRAK052686, was found strongly correlated with the antioxidant factor Nrf2, and both genes were down-regulated by the steatotic liver. The reduced expression of MRAK052686 and Nrf2 was completely reversed by BBR treatment, suggesting a new mechanism accounting for the therapeutic effect of BBR. |
25623289 |
LncRNADisease
|